We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Stroke Deadline Missed by Many

By HospiMedica staff writers
Posted on 01 Mar 2006
Only a small fraction of people who are undergoing a stroke arrive at a hospital within the necessary three hours needed to receive recombinant tissue plasminogen activator (tPA), which can dissolve the clot and reduce the chance of permanent disability.

In a study involving 15 hospitals in Michigan, researchers identified everyone who was admitted to the hospital with a stroke over a six-month period. More...
Of the 2,097 people who had strokes involving blood clots, only 43 people, or 2%, received the clot-busting drug. Of those who did not receive treatment, 41% arrived at the hospital more than three hours after the first symptom started. For another 38%, there was no information available about when the symptoms started. The study was published in the February 14, 2006, issue of Neurology.

Several factors increased the chances that tPA would be given. Those who arrived at the hospital by ambulance were seven times more likely to receive tPA than those who arrived on their own. Women were 60% less likely to receive tPA than men, and the sooner people arrived at the hospital within the three-hour window, the more likely they were to receive tPA. Of those who did arrive within three hours and did not receive the treatment, the two main reasons for not giving tPA were that the patient's condition had improved significantly, or that the stroke was considered too mild to require treatment.

"It's very important to be able to tell the medical staff when the symptoms started, said study author Mathew Reeves, Ph.D., of Michigan State University (East Lansing, USA). It could mean the difference between receiving treatment and not receiving treatment.



Related Links:
Michigan State University

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.